Sequential chemotherapy for advanced epithelial ovarian cancer: Platinum combination cytoreduction followed by cyclophosphamide consolidation
- 1 December 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (12) , 1479-1483
- https://doi.org/10.1016/0277-5379(85)90242-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: Effect of treatment and incidence of intracranial metastasesJournal of Surgical Oncology, 1983
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)Cancer, 1981
- ADVANCED OVARIAN-CANCER - BRIEF INTENSIVE COMBINATION CHEMOTHERAPY AND 2ND-LOOK OPERATION1981
- MATHEMATIC MODEL FOR RELATING THE DRUG SENSITIVITY OF TUMORS TO THEIR SPONTANEOUS MUTATION-RATE1979
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978